Retractable Technologies Inc (RVP)
0.7234
+0.01
(+1.86%)
USD |
NYAM |
Nov 04, 16:00
0.7217
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Research and Development Expense (TTM): 0.654M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.654M |
| March 31, 2024 | 0.5937M |
| December 31, 2023 | 0.5812M |
| September 30, 2023 | 0.5375M |
| June 30, 2023 | 0.4923M |
| March 31, 2023 | 0.5599M |
| December 31, 2022 | 0.5257M |
| September 30, 2022 | 0.5615M |
| June 30, 2022 | 0.655M |
| March 31, 2022 | 0.8476M |
| December 31, 2021 | 0.9014M |
| September 30, 2021 | 0.9227M |
| June 30, 2021 | 0.8581M |
| March 31, 2021 | 0.5853M |
| December 31, 2020 | 0.5745M |
| September 30, 2020 | 0.5376M |
| June 30, 2020 | 0.5379M |
| March 31, 2020 | 0.5272M |
| December 31, 2019 | 0.5161M |
| September 30, 2019 | 0.5671M |
| June 30, 2019 | 0.5786M |
| March 31, 2019 | 0.6046M |
| December 31, 2018 | 0.6214M |
| September 30, 2018 | 0.707M |
| June 30, 2018 | 0.7204M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.7363M |
| December 31, 2017 | 0.7406M |
| September 30, 2017 | 0.6479M |
| June 30, 2017 | 0.6059M |
| March 31, 2017 | 0.5954M |
| December 31, 2016 | 0.5718M |
| September 30, 2016 | 0.5875M |
| June 30, 2016 | 0.5953M |
| March 31, 2016 | 0.6161M |
| December 31, 2015 | 0.6075M |
| September 30, 2015 | 0.5204M |
| June 30, 2015 | 0.5238M |
| March 31, 2015 | 0.5484M |
| December 31, 2014 | 0.6168M |
| September 30, 2014 | 0.695M |
| June 30, 2014 | 0.8338M |
| March 31, 2014 | 0.8409M |
| December 31, 2013 | 0.8371M |
| September 30, 2013 | 0.9191M |
| June 30, 2013 | 0.8951M |
| March 31, 2013 | 0.8612M |
| December 31, 2012 | 0.8719M |
| September 30, 2012 | 0.8769M |
| June 30, 2012 | 0.8021M |
| March 31, 2012 | 0.8163M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.4923M
Minimum
Jun 2023
0.9227M
Maximum
Sep 2021
0.63M
Average
0.5745M
Median
Dec 2020
Research and Development Expense (TTM) Benchmarks
| Plus Therapeutics Inc | 10.82M |
| Perspective Therapeutics Inc | 28.53M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |